SureTrader Advertisement Advertisement
Home > Boards > Free Zone > Health and Sciences > Biotech Values


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
ghmm Member Profile
Member Level 
Followed By 42
Posts 5,854
Boards Moderated 0
Alias Born 01/22/06
160x600 placeholder
Stocks Close Slightly Higher As Jump In Oil Prices Boosts Energy Shares
U.S. airliners and online-travel brands take a hit after Turkey downs Russian jet U.S. stocks closed slightly higher Tuesday, buoyed by a...
Top Equities Stories Of The Day
Pfizer's Allergan Deal Offers Ireland Few New Benefits
Airbus Gains Regulatory Approval for New A320neo Plane
With Merger Looming, Pfizer Weighs Plan To Split In Two
SunEdison's TerraForm Affiliates Shake Up Management
Ackman's Pershing Buys More Of Valeant
Morgan Stanley Hires $5 Billion Team From Credit Suisse -- Street Moves
Intel Taps Rival For Chip Talent
Justice Department Probing Comcast's Role in 'Spot' Cable Ad Sales Market
ghmm Member Level  Friday, 12/20/13 02:33:34 PM
Re: ghmm post# 171419
Post # of 197683 

Intrexon to Acquire Medistem to Generate Multipotent Cells

Medistem's Stem Cell Technology to be Integrated Into Intrexon's Proprietary Synthetic Biology Platform

I don't follow Intrexon and don't really know what Kirk means by synthetic biology sure seems he has done a wide array of (albeit smaller) deals I don't follow the connection(s) though.

Quote: acquire, for approximately $26 million, San Diego-based Medistem, Inc. (MEDS) a pioneer in the development of Endometrial Regenerative Cells ... Pursuant to the definitive agreement, Medistem stockholders will receive in exchange for each share of Medistem common stock $0.27 in cash and $1.08 worth of Intrexon common stock, based on the 20-day volume-weighted average price of Intrexon's common stock immediately prior to closing.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist